All Stories

  1. Cerebral haemodynamics and white matter hyperintensities: findings using non-invasive brain imaging
  2. Visual versus region-of-interest based diffusion evaluation and their diagnostic impact in adult-type diffuse gliomas
  3. Comparative evaluation of single- and multi-delay arterial spin labeling MRI in preterm neonates
  4. Age-related changes in cerebral blood flow and arterial transit time in children: insights from single- and multi-delay ASL
  5. Effect of metabolic syndrome severity on cerebral haemodynamics and cognition in community-based cohort
  6. Cerebral perfusion differences in the visual cortex and fusiform subregions across the psychosis spectrum
  7. Multi-cohort, multi-sequence harmonisation for cerebrovascular brain age
  8. Blood-brain barrier water permeability across the adult lifespan: A multi-echo ASL study
  9. Associations between potential risk factors and blood-brain barrier water permeability in middle-aged and older adults
  10. Advantages and challenges of using arterial spin labelling MRI to monitor cerebral blood flow in multi-centre clinical trials of neurodegenerative disease: Experience from the RADAR study
  11. Multi-cohort, multi-sequence harmonisation for cerebrovascular brain age
  12. Associations of life-course cardiovascular risk factors with late-life cerebral hemodynamics
  13. Preoperative prediction of diffuse glioma type and grade in adults: a gadolinium-free MRI-based decision tree
  14. Human performance in predicting enhancement quality of gliomas using gadolinium‐free MRI sequences
  15. Deep learning based bilateral filtering for edge-preserving denoising of respiratory-gated PET
  16. Ten Years of VASARI Glioma Features: Systematic Review and Meta-Analysis of Their Impact and Performance
  17. Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results
  18. Reproducibility of arterial spin labeling cerebral blood flow image processing: A report of the ISMRM open science initiative for perfusion imaging (OSIPI) and the ASL MRI challenge
  19. A guide to advanced MRI processing for clinical glioma research
  20. Developing blood-brain barrier arterial spin labelling as a non-invasive early biomarker of Alzheimer’s disease (DEBBIE-AD): a prospective observational multicohort study protocol
  21. Brain Tumor Imaging without Gadolinium-based Contrast Agents: Feasible or Fantasy?
  22. Diffuse glioma molecular profiling with arterial spin labeling and dynamic susceptibility contrast perfusion MRI: A comparative study
  23. MRI-based parameter inference for cerebral perfusion modelling in health and ischaemic stroke
  24. ASL lexicon and reporting recommendations: A consensus report from the ISMRM Open Science Initiative for Perfusion Imaging (OSIPI)
  25. ISMRM Open Science Initiative for Perfusion Imaging (OSIPI): ASL pipeline inventory
  26. Effect of Physical Exercise on MRI‐Assessed Brain Perfusion in Chemotherapy‐Treated Breast Cancer Patients: A Randomized Controlled Trial
  27. Genetic, vascular and amyloid components of cerebral blood flow in a preclinical population
  28. Imaging blood-brain barrier dysfunction: A state-of-the-art review from a clinical perspective
  29. Supplementary Figure SF1 from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  30. Supplementary Data S1-2 from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  31. Supplementary Data from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  32. Data from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  33. Supplementary Data S1-2 from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  34. Supplementary Figure SF3 from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  35. Supplementary Figure SF2 from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  36. Supplementary Data from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  37. Supplementary Figure SF1 from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  38. Data from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  39. Supplementary Figure SF3 from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  40. Supplementary Figure SF2 from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  41. AdvancedMRTechniques for Preoperative Glioma Characterization: Part 2
  42. Advanced MR Techniques for Preoperative Glioma Characterization: Part 1
  43. The value of arterial spin labelling perfusion MRI in brain age prediction
  44. Current state and guidance on arterial spin labeling perfusion MRI in clinical neuroimaging
  45. Editorial for “MRI Assessment of Cerebral Blood Flow in Nonhospitalized Adults Who Self‐Isolated Due to COVID‐19”
  46. Association of Arterial Spin Labeling Parameters With Cognitive Decline, Vascular Events, and Mortality in a Memory-Clinic Sample
  47. Reply: Cerebral Blood Flow of the Frontal Lobe in Untreated Children with Trigonocephaly versus Healthy Controls: An Arterial Spin Labeling Study
  48. Arterial Spin-Labeling Parameters and Their Associations with Risk Factors, Cerebral Small-Vessel Disease, and Etiologic Subtypes of Cognitive Impairment and Dementia
  49. MRI-based computational model generation for cerebral perfusion simulations in health and ischaemic stroke
  50. ASL-BIDS, the brain imaging data structure extension for arterial spin labeling
  51. Recent Technical Developments in ASL: A Review of the State of the Art
  52. A Beginner's Guide to Arterial Spin Labeling (ASL) Image Processing
  53. Reproducibility of 3 T APT‐CEST in Healthy Volunteers and Patients With Brain Glioma
  54. Cerebral Blood Flow of the Frontal Lobe in Untreated Children with Trigonocephaly versus Healthy Controls: An Arterial Spin Labeling Study
  55. Atherosclerotic risk is associated with cerebral perfusion – A cross-sectional study using arterial spin labeling MRI
  56. The Open-Access European Prevention of Alzheimer’s Dementia (EPAD) MRI dataset and processing workflow
  57. Cerebral perfusion and the risk of cognitive decline and dementia in community dwelling older people
  58. A systematic review on the use of quantitative imaging to detect cancer therapy adverse effects in normal-appearing brain tissue
  59. ASL-BIDS, the brain imaging data structure extension for arterial spin labeling
  60. The European Prevention of Alzheimer’s Dementia (EPAD) MRI Dataset and Processing Workflow
  61. Using Perfusion Contrast for Spatial Normalization of ASL MRI Images in a Pediatric Craniosynostosis Population
  62. Epileptogenic zone detection in MRI negative epilepsy using adaptive thresholding of arterial spin labeling data
  63. Overestimation of grey matter atrophy in glioblastoma patients following radio(chemo)therapy
  64. Arterial spin labeling: Adaptive thresholding for epileptogenic zone detection in MRI-negative epilepsy
  65. Final Results of the Prospective Biomarker Trial PETra: [11C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  66. The Effects of Intracranial Stenosis on Cerebral Perfusion and Cognitive Performance
  67. From research to clinical practice: a European neuroradiological survey on quantitative advanced MRI implementation
  68. Longitudinal relation between blood pressure, antihypertensive use and cerebral blood flow, using arterial spin labelling MRI
  69. GliMR: Cross-Border Collaborations to Promote Advanced MRI Biomarkers for Glioma
  70. Effects of Acquisition Parameter Modifications and Field Strength on the Reproducibility of Brain Perfusion Measurements Using Arterial Spin-Labeling
  71. ExploreASL: An image processing pipeline for multi-center ASL perfusion MRI studies
  72. Dose dependent cerebellar atrophy in glioma patients after radio(chemo)therapy
  73. Accurate MR Image Registration to Anatomical Reference Space for Diffuse Glioma
  74. Hemodynamic impairments within individual watershed areas in asymptomatic carotid artery stenosis by multimodal MRI
  75. Spatial coefficient of variation of arterial spin labeling MRI as a cerebrovascular correlate of carotid occlusive disease
  76. Cerebral oxygen metabolism in adults with sickle cell disease
  77. ExploreASL: an image processing pipeline for multi-center ASL perfusion MRI studies
  78. Late-life brain perfusion after prenatal famine exposure
  79. Cortical microinfarcts in memory clinic patients are associated with reduced cerebral perfusion
  80. Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study
  81. Cerebrovascular Reactivity during Prolonged Breath-Hold in Experienced Freedivers
  82. Photon vs. proton radiochemotherapy: Effects on brain tissue volume and perfusion
  83. Effects of systematic partial volume errors on the estimation of gray matter cerebral blood flow with arterial spin labeling MRI
  84. EP-2137: Development of a modular MRI processing workflow for volumetric analysis of healthy brain tissue
  85. OC-0594: Postoperative [11C]MET-PET predicts radiochemotherapy outcome in glioblastoma: a prospective trial
  86. Comparison of arterial spin labeling registration strategies in the multi-center GENetic frontotemporal dementia initiative (GENFI)
  87. The spatial coefficient of variation in arterial spin labeling cerebral blood flow images
  88. Moments-Based Ultrasound Visual Servoing: From a Mono- to Multiplane Approach
  89. Early and late effects of radiochemotherapy on cerebral blood flow in glioblastoma patients measured with non-invasive perfusion MRI
  90. Correction of quantification errors in pelvic and spinal lesions caused by ignoring higher photon attenuation of bone in [18F]NaF PET/MR
  91. Evaluation of in vivo quantification accuracy of the Ingenuity-TF PET/MR
  92. Accuracy of Parenchymal Cerebral Blood Flow Measurements Using Pseudocontinuous Arterial Spin-Labeling in Healthy Volunteers
  93. Partial Volume Correction of Cerebral Perfusion Estimates Obtained by Arterial Spin Labeling
  94. Stability of MR brain-perfusion measurement using arterial spin labeling
  95. Evaluation and automatic correction of metal-implant-induced artifacts in MR-based attenuation correction in whole-body PET/MR imaging
  96. Erratum to: Quantitative accuracy of attenuation correction in the Philips Ingenuity TF whole-body PET/MR system: a direct comparison with transmission-based attenuation correction
  97. Correction of scan time dependence of standard uptake values in oncological PET
  98. Modeling magnetization transfer effects of Q2TIPS bolus saturation in multi-TI pulsed arterial spin labeling
  99. Influence and Compensation of Truncation Artifacts in MR-Based Attenuation Correction in PET/MR
  100. Template-based approach for detecting motor task activation-related hyperperfusion in pulsed ASL data
  101. The PET-derived tumor-to-blood standard uptake ratio (SUR) is superior to tumor SUV as a surrogate parameter of the metabolic rate of FDG
  102. An automatic method for accurate volume delineation of heterogeneous tumors in PET
  103. Optimal Individual Inversion Time in Brain Arterial Spin Labeling Perfusion Magnetic Resonance Imaging
  104. Partial volume correction in arterial spin labeling using a Look-Locker sequence
  105. Quantitative accuracy of attenuation correction in the Philips Ingenuity TF whole-body PET/MR system: a direct comparison with transmission-based attenuation correction
  106. Functional arterial spin labeling: Optimal sequence duration for motor activation mapping in clinical practice
  107. Arterial spin labelling fonctionnel : durée de séquence optimale pour cartographier l’activation motrice en routine clinique
  108. Improving quality of arterial spin labeling MR imaging at 3 tesla with a 32-channel coil and parallel imaging
  109. A method for model-free partial volume correction in oncological PET
  110. Innovations en IRM fonctionnelle cérébrale : marquage de spins artériels et diffusion
  111. Arterial spin labeling for motor activation mapping at 3T with a 32-channel coil: Reproducibility and spatial accuracy in comparison with BOLD fMRI
  112. Evaluation of functional arterial spin labeling data using a perfusion template
  113. Construction and evaluation of a quantitative arterial spin labeling brain perfusion template at 3T
  114. Improving arterial spin labeling data by temporal filtering
  115. Denoising arterial spin labeling MRI using tissue partial volume
  116. Continuous criterion for parallel MRI reconstruction using B-spline approximation (PROBER)
  117. Parallel image reconstruction using B-spline approximation (PROBER)
  118. Fast parallel MRI reconstruction using B-spline approximation (PROBER)